City

Aarhus (1)

Aurora (1)

Bristol (1)

Jette (1)

Nijmegen (1)

Rochester (1)

Overall Status

Recruiting (3)

Completed (1)

Not yet recruiting (1)

Phase

n/a (1)

phase 2 (1)

Sponsor

Mayo Clinic (1)

Radboud University Medical Center (1)

UK Kidney Association (1)

Universitair Ziekenhuis Brussel (1)

University of Colorado, Denver (1)

Collaborator

Hopital du Sacre-Coeur de Montreal (1)

University of Aarhus (1)

Intervention

calcitonin (1)

deamino arginine vasopressin (ddavp) (1)

hydrochlorothiazide/amiloride (1)

indomethacin (1)

pb (1)

placebo for calcitonin (1)

placebo for sildenafil (1)

sevoflurane (1)

sildenafil (1)

Study Documents

Intervention Type

drug (3)

diagnostic test (1)

Funder Type

Other (5)

Study Type

Interventional (2)

Observational (2)

Observational [Patient Registry] (1)

nephrogenic diabetes insipidus

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

Recruiting

Adenine Phosphoribosyltransferase Deficiency
+83 more

Bristol, South West, United Kingdom

Zoe Plummer

Sep 26, 2023

Lithium Treated Patients

Not yet recruiting

Lithium Toxicities
+4 more

Deamino Arginine Vasopressin (dDAVP)

Nijmegen, Gelderland, Netherlands

Canisius Wilhelmina Ziekenhuis

Mar 23, 2022

Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus, Acquired Nephrogenic Diabetes Insipidus Trial in

Recruiting

Autosomal Dominant Polycystic Kidney Disease
+3 more

Rochester, Minnesota

Mayo Clinic Rochester

Feb 14, 2022

Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane

Recruiting

Nephrogenic Diabetes Insipidus

Sevoflurane

Jette, Brussel, Belgium

UZ Brussel

Nov 3, 2021

Nephrogenic Diabetes Insipidus Trial in Aurora, Aarhus (sildenafil, calcitonin, hydrochlorothiazide/amiloride)

Completed

Has Results

Nephrogenic Diabetes Insipidus

sildenafil
+5 more

Aurora, Colorado
+1 more

Feb 8, 2018